Literature DB >> 35785478

Oligofructose restores postprandial short-chain fatty acid levels during high-fat feeding.

Rachel K Meyer1, Adelina I Lane2, Savanna N Weninger2, Taylor M Martinez2, Archana Kangath3, Daniel Laubitz4, Frank A Duca3,5.   

Abstract

OBJECTIVE: Obesity is associated with consumption of a Western diet low in dietary fiber, while prebiotics reduce body weight. Fiber induces short-chain fatty acid (SCFA) production, and SCFA administration is beneficial to host metabolic homeostasis. However, the role of endogenous SCFA signaling in the development of obesity is contentious. Therefore, the primary objective of this study is to evaluate the postprandial time course of SCFA production and uptake in healthy (chow-fed), Western diet-fed (high-fat diet [HFD]) obese, and oligofructose-treated HFD-fed (HFD + OFS) rats.
METHODS: Male Sprague-Dawley rats were maintained on chow or HFD for 5 weeks, with or without supplementation of 10% OFS for 3 weeks. SCFAs were measured in the ileum, cecum, colon, portal vein, and vena cava at 0, 2, 4, 6, and 8 hours postprandially.
RESULTS: Postprandial cecal and portal vein SCFAs were decreased in obese rats compared with lean chow controls, whereas no differences were observed in fasting SCFA concentrations. OFS supplementation increased SCFA levels in the cecum and portal vein during obesity. Butyrate levels were positively associated with portal glucagon-like peptide 1 and adiposity and with Roseburia relative abundance.
CONCLUSIONS: The current study demonstrates that obesity is associated with reduced SCFA production, and that OFS supplementation increases SCFA levels. Additionally, postprandial butyrate production appears to be beneficial to host energy homeostasis.
© 2022 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35785478      PMCID: PMC9260920          DOI: 10.1002/oby.23456

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   9.298


  43 in total

Review 1.  Nondigestibility characteristics of inulin and oligofructose in humans.

Authors:  H B Andersson; L H Ellegård; I G Bosaeus
Journal:  J Nutr       Date:  1999-07       Impact factor: 4.798

2.  Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

Authors:  Patrice D Cani; Claude Knauf; Miguel A Iglesias; Daniel J Drucker; Nathalie M Delzenne; Rémy Burcelin
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

3.  Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

Authors:  Patrice D Cani; Audrey M Neyrinck; Nicole Maton; Nathalie M Delzenne
Journal:  Obes Res       Date:  2005-06

4.  Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.

Authors:  Lijuan Zhao; Hongxiang Lou; Ying Peng; Shihong Chen; Yulong Zhang; Xiaobo Li
Journal:  Endocrine       Date:  2019-10-07       Impact factor: 3.633

Review 5.  The role of mucin and oligosaccharides via cross-feeding activities by Bifidobacterium: A review.

Authors:  Yanhong Luo; Yue Xiao; Jianxin Zhao; Hao Zhang; Wei Chen; Qixiao Zhai
Journal:  Int J Biol Macromol       Date:  2020-11-14       Impact factor: 6.953

6.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

7.  Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids.

Authors:  Martin Trapecar; Catherine Communal; Jason Velazquez; Christian Alexander Maass; Yu-Ja Huang; Kirsten Schneider; Charles W Wright; Vincent Butty; George Eng; Omer Yilmaz; David Trumper; Linda G Griffith
Journal:  Cell Syst       Date:  2020-03-18       Impact factor: 10.304

8.  Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.

Authors:  Jun-Ichi Minami; Shizuki Kondo; Naotake Yanagisawa; Toshitaka Odamaki; Jin-Zhong Xiao; Fumiaki Abe; Shigeru Nakajima; Yukie Hamamoto; Sanae Saitoh; Taeko Shimoda
Journal:  J Nutr Sci       Date:  2015-05-04

9.  The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases.

Authors:  Ron Caspi; Tomer Altman; Richard Billington; Kate Dreher; Hartmut Foerster; Carol A Fulcher; Timothy A Holland; Ingrid M Keseler; Anamika Kothari; Aya Kubo; Markus Krummenacker; Mario Latendresse; Lukas A Mueller; Quang Ong; Suzanne Paley; Pallavi Subhraveti; Daniel S Weaver; Deepika Weerasinghe; Peifen Zhang; Peter D Karp
Journal:  Nucleic Acids Res       Date:  2013-11-12       Impact factor: 16.971

10.  Bacterial Microbiota and Fatty Acids in the Faeces of Overweight and Obese Children.

Authors:  Renata Barczyńska; Mieczysław Litwin; Katarzyna Sliżewska; Mieczyslaw Szalecki; Agnieszka Berdowska; Katarzyna Bandurska; Zdzisława Libudzisz; Janusz Kapuśniak
Journal:  Pol J Microbiol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.